

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.25092504 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.25092504 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.01770360 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.01770360 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.64382308 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.14419535 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.14419535 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.14419535 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.89009421 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.84831306 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.83890846 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.77161131 |
| 13 | cysteine metabolic process (GO:0006534) | 5.65765451 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.60803881 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 5.51803726 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47336343 |
| 17 | lysine metabolic process (GO:0006553) | 5.40632435 |
| 18 | lysine catabolic process (GO:0006554) | 5.40632435 |
| 19 | serine family amino acid catabolic process (GO:0009071) | 5.39457346 |
| 20 | urea cycle (GO:0000050) | 5.20352764 |
| 21 | urea metabolic process (GO:0019627) | 5.20352764 |
| 22 | homocysteine metabolic process (GO:0050667) | 5.14070547 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.08178429 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.03657197 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 4.90008495 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 4.84124059 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.81037222 |
| 28 | * alpha-amino acid catabolic process (GO:1901606) | 4.76302253 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.75466873 |
| 30 | bile acid metabolic process (GO:0008206) | 4.74321304 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.62927808 |
| 32 | negative regulation of fibrinolysis (GO:0051918) | 4.62917079 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.61949560 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.60575551 |
| 35 | protein carboxylation (GO:0018214) | 4.60575551 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.55718816 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.49028704 |
| 38 | * cellular amino acid catabolic process (GO:0009063) | 4.48064649 |
| 39 | serine family amino acid metabolic process (GO:0009069) | 4.47886089 |
| 40 | regulation of fibrinolysis (GO:0051917) | 4.47367229 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.45884871 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.45884871 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.45056242 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.43462658 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.43462658 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.43462658 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.43159258 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 4.41792439 |
| 49 | glycine metabolic process (GO:0006544) | 4.41612343 |
| 50 | short-chain fatty acid metabolic process (GO:0046459) | 4.40896767 |
| 51 | ethanol oxidation (GO:0006069) | 4.38756237 |
| 52 | * cellular modified amino acid catabolic process (GO:0042219) | 4.36012492 |
| 53 | drug transmembrane transport (GO:0006855) | 4.35123764 |
| 54 | drug catabolic process (GO:0042737) | 4.34986162 |
| 55 | regulation of complement activation (GO:0030449) | 4.33626329 |
| 56 | serine family amino acid biosynthetic process (GO:0009070) | 4.32924315 |
| 57 | cellular glucuronidation (GO:0052695) | 4.31395567 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.31028663 |
| 59 | amine catabolic process (GO:0009310) | 4.30229781 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.30229781 |
| 61 | coenzyme catabolic process (GO:0009109) | 4.25391929 |
| 62 | urate metabolic process (GO:0046415) | 4.22556489 |
| 63 | * glutamate metabolic process (GO:0006536) | 4.21357039 |
| 64 | low-density lipoprotein particle remodeling (GO:0034374) | 4.09824123 |
| 65 | triglyceride homeostasis (GO:0070328) | 4.09483281 |
| 66 | acylglycerol homeostasis (GO:0055090) | 4.09483281 |
| 67 | phospholipid efflux (GO:0033700) | 4.05949071 |
| 68 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05848719 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.02681758 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.02467415 |
| 71 | regulation of guanylate cyclase activity (GO:0031282) | 4.02082476 |
| 72 | aspartate family amino acid catabolic process (GO:0009068) | 3.99833931 |
| 73 | 2-oxoglutarate metabolic process (GO:0006103) | 3.96874800 |
| 74 | exogenous drug catabolic process (GO:0042738) | 3.94954868 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.93663828 |
| 76 | acetyl-CoA metabolic process (GO:0006084) | 3.93573660 |
| 77 | * organic acid catabolic process (GO:0016054) | 3.93529094 |
| 78 | * carboxylic acid catabolic process (GO:0046395) | 3.93529094 |
| 79 | valine metabolic process (GO:0006573) | 3.87087913 |
| 80 | uronic acid metabolic process (GO:0006063) | 3.85507889 |
| 81 | glucuronate metabolic process (GO:0019585) | 3.85507889 |
| 82 | arginine metabolic process (GO:0006525) | 3.83309312 |
| 83 | ketone body metabolic process (GO:1902224) | 3.82158502 |
| 84 | drug transport (GO:0015893) | 3.78211737 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 3.78102800 |
| 86 | carnitine metabolic process (GO:0009437) | 3.76250904 |
| 87 | aldehyde catabolic process (GO:0046185) | 3.75434959 |
| 88 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74306950 |
| 89 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.73252778 |
| 90 | fatty acid beta-oxidation (GO:0006635) | 3.72751045 |
| 91 | flavonoid metabolic process (GO:0009812) | 3.71969615 |
| 92 | fatty acid oxidation (GO:0019395) | 3.70568793 |
| 93 | lipid oxidation (GO:0034440) | 3.68311532 |
| 94 | plasma lipoprotein particle assembly (GO:0034377) | 3.65195283 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.63565518 |
| 96 | cholesterol efflux (GO:0033344) | 3.62434476 |
| 97 | central nervous system myelination (GO:0022010) | 3.61226968 |
| 98 | axon ensheathment in central nervous system (GO:0032291) | 3.61226968 |
| 99 | * monocarboxylic acid catabolic process (GO:0072329) | 3.57381452 |
| 100 | fatty acid catabolic process (GO:0009062) | 3.52854229 |
| 101 | drug metabolic process (GO:0017144) | 3.51951491 |
| 102 | branched-chain amino acid catabolic process (GO:0009083) | 3.51096150 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.50508503 |
| 104 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.50490031 |
| 105 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.50490031 |
| 106 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.44101650 |
| 107 | vitamin transmembrane transport (GO:0035461) | 3.43433158 |
| 108 | lung epithelium development (GO:0060428) | 3.43404017 |
| 109 | regulation of female receptivity (GO:0045924) | 3.38494541 |
| 110 | angiotensin maturation (GO:0002003) | 3.35718582 |
| 111 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.27933032 |
| 112 | female mating behavior (GO:0060180) | 3.24135026 |
| 113 | alkaloid metabolic process (GO:0009820) | 3.22287578 |
| 114 | vocalization behavior (GO:0071625) | 2.99648513 |
| 115 | gamma-aminobutyric acid transport (GO:0015812) | 2.96967078 |
| 116 | NADH metabolic process (GO:0006734) | 2.95120650 |
| 117 | primary alcohol catabolic process (GO:0034310) | 2.94375240 |
| 118 | renal system process involved in regulation of blood volume (GO:0001977) | 2.92203286 |
| 119 | sodium ion homeostasis (GO:0055078) | 2.91202216 |
| 120 | postsynaptic membrane organization (GO:0001941) | 2.90335484 |
| 121 | ethanol metabolic process (GO:0006067) | 2.89225942 |
| 122 | alanine transport (GO:0032328) | 2.88770107 |
| 123 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.82592447 |
| 124 | proline transport (GO:0015824) | 2.82336142 |
| 125 | cell migration in hindbrain (GO:0021535) | 2.81359828 |
| 126 | heme transport (GO:0015886) | 2.80067623 |
| 127 | iron coordination entity transport (GO:1901678) | 2.79143714 |
| 128 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.76746641 |
| 129 | regulation of gene silencing by RNA (GO:0060966) | 2.76605185 |
| 130 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.76605185 |
| 131 | regulation of gene silencing by miRNA (GO:0060964) | 2.76605185 |
| 132 | regulation of cGMP biosynthetic process (GO:0030826) | 2.75933644 |
| 133 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74405566 |
| 134 | C4-dicarboxylate transport (GO:0015740) | 2.73862198 |
| 135 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.72416937 |
| 136 | neurotransmitter catabolic process (GO:0042135) | 2.72326158 |
| 137 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72144687 |
| 138 | L-ascorbic acid metabolic process (GO:0019852) | 2.66741166 |
| 139 | L-amino acid import (GO:0043092) | 2.61791898 |
| 140 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.60927010 |
| 141 | oxidative demethylation (GO:0070989) | 2.60296574 |
| 142 | vitamin transport (GO:0051180) | 2.59320295 |
| 143 | one-carbon compound transport (GO:0019755) | 2.59172513 |
| 144 | fructose metabolic process (GO:0006000) | 2.58771580 |
| 145 | cGMP-mediated signaling (GO:0019934) | 2.58514435 |
| 146 | cellular response to nitric oxide (GO:0071732) | 2.53206738 |
| 147 | neurotransmitter secretion (GO:0007269) | 2.52175766 |
| 148 | phosphate ion transmembrane transport (GO:0035435) | 2.48344771 |
| 149 | ovulation cycle (GO:0042698) | 2.44500430 |
| 150 | response to dietary excess (GO:0002021) | 2.44302829 |
| 151 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.42954174 |
| 152 | regulation of neurotransmitter levels (GO:0001505) | 2.40710685 |
| 153 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.40103898 |
| 154 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.40103898 |
| 155 | neurotransmitter transport (GO:0006836) | 2.39696588 |
| 156 | nucleobase catabolic process (GO:0046113) | 2.39537549 |
| 157 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.39405761 |
| 158 | trivalent inorganic anion homeostasis (GO:0072506) | 2.38854740 |
| 159 | phosphate ion homeostasis (GO:0055062) | 2.38854740 |
| 160 | cornea development in camera-type eye (GO:0061303) | 2.38706045 |
| 161 | auditory behavior (GO:0031223) | 2.37772089 |
| 162 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.37732814 |
| 163 | hormone catabolic process (GO:0042447) | 2.37698493 |
| 164 | transepithelial transport (GO:0070633) | 2.37022085 |
| 165 | arginine catabolic process (GO:0006527) | 2.36364229 |
| 166 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.35561270 |
| 167 | diacylglycerol metabolic process (GO:0046339) | 2.32714636 |
| 168 | intestinal absorption (GO:0050892) | 2.32634902 |
| 169 | glutathione biosynthetic process (GO:0006750) | 2.32530164 |
| 170 | synaptic vesicle maturation (GO:0016188) | 2.30111405 |
| 171 | presynaptic membrane assembly (GO:0097105) | 2.29754435 |
| 172 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.29273738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.23540047 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09379943 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.67674887 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.27649320 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.44385564 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14653804 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.81948422 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.92459469 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79049224 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.00165119 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.94570110 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.59481497 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.41845338 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24721838 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.20705437 |
| 16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.16597217 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11823905 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.11625827 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09686656 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.07022494 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07017004 |
| 22 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.01069386 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7984848 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95774853 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.88912948 |
| 26 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78046212 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73078429 |
| 28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.65877349 |
| 29 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.63348992 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62665167 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.62501104 |
| 32 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.56272477 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.53811352 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.53811352 |
| 35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.52538858 |
| 36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52000517 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.51201507 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49848263 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44400678 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43679285 |
| 41 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43223096 |
| 42 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43165332 |
| 43 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.39643302 |
| 44 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.36652938 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32555397 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32208383 |
| 47 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.31805414 |
| 48 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.30034342 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26420747 |
| 50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.26121856 |
| 51 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23420796 |
| 52 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22284401 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22000120 |
| 54 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21640403 |
| 55 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.20106598 |
| 56 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.17287483 |
| 57 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16681926 |
| 58 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16160510 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16125215 |
| 60 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14796035 |
| 61 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.13916805 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13815221 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.12189021 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.11869841 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11793791 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10892605 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10339582 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10004718 |
| 69 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09329951 |
| 70 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08533010 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08484204 |
| 72 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.06480254 |
| 73 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04788919 |
| 74 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04092860 |
| 75 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.03021424 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01975158 |
| 77 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01259320 |
| 78 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00926480 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.99784771 |
| 80 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99489069 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98710020 |
| 82 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98545414 |
| 83 | ERA_21632823_ChIP-Seq_H3396_Human | 0.96377248 |
| 84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96323569 |
| 85 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93288897 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92461392 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91562214 |
| 88 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91264189 |
| 89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91076922 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90511340 |
| 91 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.90473793 |
| 92 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.90189705 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90173674 |
| 94 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89520561 |
| 95 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89520109 |
| 96 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89186383 |
| 97 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.87767472 |
| 98 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87217282 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.86096385 |
| 100 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.84548556 |
| 101 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84524274 |
| 102 | AR_19668381_ChIP-Seq_PC3_Human | 0.83656933 |
| 103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83581423 |
| 104 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83401479 |
| 105 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83361469 |
| 106 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.82814559 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82652212 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.82599754 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82520279 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81335658 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81157631 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78765851 |
| 113 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74572373 |
| 114 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72524290 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.72040916 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.71587108 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71056429 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.70726732 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70474403 |
| 120 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.69361955 |
| 121 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69359422 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65849999 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64857133 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62580101 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61864449 |
| 126 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58771092 |
| 127 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.57543441 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.55814570 |
| 129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.55047901 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.54720562 |
| 131 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53927617 |
| 132 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53142536 |
| 133 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.53108482 |
| 134 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51496867 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.51056013 |
| 136 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.50375373 |
| 137 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49637429 |
| 138 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49480533 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49305054 |
| 140 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.48105318 |
| 141 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47874590 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47692294 |
| 143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47330060 |
| 144 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.46871715 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46554129 |
| 146 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.46145205 |
| 147 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45839665 |
| 148 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.45419715 |
| 149 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.45238340 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44449063 |
| 151 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.44212659 |
| 152 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.44212659 |
| 153 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.43000884 |
| 154 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42846343 |
| 155 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42792529 |
| 156 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42655519 |
| 157 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41785326 |
| 158 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.41669831 |
| 159 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.41632425 |
| 160 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.41270537 |
| 161 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40328334 |
| 162 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.39815246 |
| 163 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.39654957 |
| 164 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.39401862 |
| 165 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.38998671 |
| 166 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.38996450 |
| 167 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.38755254 |
| 168 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.38718585 |
| 169 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.38418699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.99591602 |
| 2 | MP0005360_urolithiasis | 7.79663686 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.97069164 |
| 4 | MP0005365_abnormal_bile_salt | 5.85926553 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.09254207 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08299242 |
| 7 | MP0003252_abnormal_bile_duct | 3.79894241 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.36391020 |
| 9 | * MP0005332_abnormal_amino_acid | 3.29745876 |
| 10 | MP0009840_abnormal_foam_cell | 3.14722257 |
| 11 | MP0003195_calcinosis | 2.79201194 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.65827897 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.63515949 |
| 14 | MP0005083_abnormal_biliary_tract | 2.59240098 |
| 15 | MP0004270_analgesia | 2.55153359 |
| 16 | MP0005377_hearing/vestibular/ear_phenot | 2.54880102 |
| 17 | MP0003878_abnormal_ear_physiology | 2.54880102 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.46851040 |
| 19 | MP0003136_yellow_coat_color | 2.46694721 |
| 20 | MP0004859_abnormal_synaptic_plasticity | 2.11481855 |
| 21 | MP0003880_abnormal_central_pattern | 2.11441501 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.10021248 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 2.02890627 |
| 24 | MP0000609_abnormal_liver_physiology | 2.01697326 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.97420504 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.92091026 |
| 27 | MP0009745_abnormal_behavioral_response | 1.89828877 |
| 28 | MP0001764_abnormal_homeostasis | 1.86726061 |
| 29 | MP0004147_increased_porphyrin_level | 1.84289603 |
| 30 | MP0002064_seizures | 1.81347831 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.78350810 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.75041782 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.74827209 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.74697255 |
| 35 | MP0003879_abnormal_hair_cell | 1.72928392 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.72142741 |
| 37 | * MP0001486_abnormal_startle_reflex | 1.70153258 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.69649040 |
| 39 | MP0003868_abnormal_feces_composition | 1.69016508 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.68509364 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.67491204 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.64968938 |
| 43 | MP0002272_abnormal_nervous_system | 1.64869685 |
| 44 | MP0003186_abnormal_redox_activity | 1.64622220 |
| 45 | MP0005423_abnormal_somatic_nervous | 1.61736460 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.51479233 |
| 47 | MP0005451_abnormal_body_composition | 1.51233229 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.50170655 |
| 49 | MP0001984_abnormal_olfaction | 1.48572793 |
| 50 | MP0002736_abnormal_nociception_after | 1.44764105 |
| 51 | MP0004133_heterotaxia | 1.43763083 |
| 52 | MP0004885_abnormal_endolymph | 1.41006708 |
| 53 | MP0002063_abnormal_learning/memory/cond | 1.40377211 |
| 54 | MP0002249_abnormal_larynx_morphology | 1.39136128 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.38326723 |
| 56 | MP0005647_abnormal_sex_gland | 1.35729357 |
| 57 | MP0009697_abnormal_copulation | 1.35450276 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.34287905 |
| 59 | MP0002098_abnormal_vibrissa_morphology | 1.34070474 |
| 60 | MP0003011_delayed_dark_adaptation | 1.33974391 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.33201361 |
| 62 | MP0003283_abnormal_digestive_organ | 1.33069458 |
| 63 | MP0002254_reproductive_system_inflammat | 1.31965880 |
| 64 | MP0003119_abnormal_digestive_system | 1.31282780 |
| 65 | MP0005636_abnormal_mineral_homeostasis | 1.28454362 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.27463803 |
| 67 | MP0002735_abnormal_chemical_nociception | 1.27386655 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.26691808 |
| 69 | MP0009764_decreased_sensitivity_to | 1.19677721 |
| 70 | MP0005670_abnormal_white_adipose | 1.19584959 |
| 71 | MP0002909_abnormal_adrenal_gland | 1.14627633 |
| 72 | MP0002733_abnormal_thermal_nociception | 1.14357818 |
| 73 | MP0000383_abnormal_hair_follicle | 1.13292983 |
| 74 | MP0004043_abnormal_pH_regulation | 1.12088685 |
| 75 | MP0001502_abnormal_circadian_rhythm | 1.11203701 |
| 76 | MP0000598_abnormal_liver_morphology | 1.10323846 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.08668767 |
| 78 | MP0001986_abnormal_taste_sensitivity | 1.07578598 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 1.07274875 |
| 80 | MP0003938_abnormal_ear_development | 1.07246119 |
| 81 | MP0001970_abnormal_pain_threshold | 1.06493225 |
| 82 | MP0000026_abnormal_inner_ear | 1.01323508 |
| 83 | MP0002938_white_spotting | 0.99161420 |
| 84 | MP0000604_amyloidosis | 0.98777532 |
| 85 | MP0001756_abnormal_urination | 0.97937299 |
| 86 | MP0004924_abnormal_behavior | 0.97758351 |
| 87 | MP0005386_behavior/neurological_phenoty | 0.97758351 |
| 88 | MP0009046_muscle_twitch | 0.95610625 |
| 89 | MP0003646_muscle_fatigue | 0.93799932 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.93723016 |
| 91 | MP0009763_increased_sensitivity_to | 0.90995789 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.90870131 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.90525369 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 0.89855393 |
| 95 | MP0001188_hyperpigmentation | 0.89444982 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.88764513 |
| 97 | MP0008469_abnormal_protein_level | 0.88647451 |
| 98 | * MP0009642_abnormal_blood_homeostasis | 0.88510390 |
| 99 | MP0005187_abnormal_penis_morphology | 0.87125114 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.86665379 |
| 101 | MP0001664_abnormal_digestion | 0.85587972 |
| 102 | MP0003787_abnormal_imprinting | 0.84774799 |
| 103 | MP0004858_abnormal_nervous_system | 0.83492700 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.82869710 |
| 105 | MP0005376_homeostasis/metabolism_phenot | 0.82177463 |
| 106 | MP0003690_abnormal_glial_cell | 0.79965055 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.76111734 |
| 108 | MP0005645_abnormal_hypothalamus_physiol | 0.75901529 |
| 109 | MP0003329_amyloid_beta_deposits | 0.74947664 |
| 110 | MP0000462_abnormal_digestive_system | 0.74904491 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.74848521 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.74635841 |
| 113 | MP0002971_abnormal_brown_adipose | 0.74297569 |
| 114 | MP0005535_abnormal_body_temperature | 0.74267877 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.73510731 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.72895818 |
| 117 | MP0001765_abnormal_ion_homeostasis | 0.72692378 |
| 118 | MP0002229_neurodegeneration | 0.72408049 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.72191478 |
| 120 | MP0000778_abnormal_nervous_system | 0.71204514 |
| 121 | MP0002066_abnormal_motor_capabilities/c | 0.70759345 |
| 122 | MP0000647_abnormal_sebaceous_gland | 0.70582009 |
| 123 | MP0010678_abnormal_skin_adnexa | 0.70436503 |
| 124 | MP0001440_abnormal_grooming_behavior | 0.69816002 |
| 125 | MP0002882_abnormal_neuron_morphology | 0.68780391 |
| 126 | MP0004130_abnormal_muscle_cell | 0.68341196 |
| 127 | MP0005266_abnormal_metabolism | 0.66223389 |
| 128 | MP0005334_abnormal_fat_pad | 0.65320510 |
| 129 | MP0001661_extended_life_span | 0.64665385 |
| 130 | MP0003638_abnormal_response/metabolism_ | 0.64037069 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.62765530 |
| 132 | MP0005408_hypopigmentation | 0.62096153 |
| 133 | MP0010368_abnormal_lymphatic_system | 0.61415943 |
| 134 | MP0006035_abnormal_mitochondrial_morpho | 0.61282996 |
| 135 | MP0003075_altered_response_to | 0.58889650 |
| 136 | MP0005058_abnormal_lysosome_morphology | 0.57196539 |
| 137 | MP0002928_abnormal_bile_duct | 0.56483040 |
| 138 | MP0001853_heart_inflammation | 0.55855994 |
| 139 | MP0003300_gastrointestinal_ulcer | 0.54274528 |
| 140 | MP0003718_maternal_effect | 0.53544422 |
| 141 | MP0005395_other_phenotype | 0.52155277 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.48593215 |
| 143 | MP0008872_abnormal_physiological_respon | 0.47571225 |
| 144 | MP0005166_decreased_susceptibility_to | 0.47307108 |
| 145 | MP0005464_abnormal_platelet_physiology | 0.45976485 |
| 146 | MP0008874_decreased_physiological_sensi | 0.44250383 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.43959647 |
| 148 | MP0003953_abnormal_hormone_level | 0.43728560 |
| 149 | MP0005448_abnormal_energy_balance | 0.42179122 |
| 150 | MP0002132_abnormal_respiratory_system | 0.41702951 |
| 151 | MP0000639_abnormal_adrenal_gland | 0.41674215 |
| 152 | MP0009115_abnormal_fat_cell | 0.40191349 |
| 153 | MP0002796_impaired_skin_barrier | 0.39979385 |
| 154 | MP0008873_increased_physiological_sensi | 0.38327424 |
| 155 | MP0002135_abnormal_kidney_morphology | 0.38170766 |
| 156 | MP0009384_cardiac_valve_regurgitation | 0.37853276 |
| 157 | MP0009053_abnormal_anal_canal | 0.37408951 |
| 158 | MP0003724_increased_susceptibility_to | 0.37262843 |
| 159 | MP0002168_other_aberrant_phenotype | 0.36217277 |
| 160 | MP0000566_synostosis | 0.36056187 |
| 161 | MP0002837_dystrophic_cardiac_calcinosis | 0.33854414 |
| 162 | MP0002822_catalepsy | 0.33282192 |
| 163 | MP0000538_abnormal_urinary_bladder | 0.32709596 |
| 164 | MP0004264_abnormal_extraembryonic_tissu | 0.31320908 |
| 165 | MP0002970_abnormal_white_adipose | 0.30708162 |
| 166 | MP0003436_decreased_susceptibility_to | 0.30605332 |
| 167 | MP0001845_abnormal_inflammatory_respons | 0.29290644 |
| 168 | MP0009672_abnormal_birth_weight | 0.29147336 |
| 169 | MP0000579_abnormal_nail_morphology | 0.28323186 |
| 170 | MP0001881_abnormal_mammary_gland | 0.27113202 |
| 171 | MP0000249_abnormal_blood_vessel | 0.26954291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.98058410 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.64185473 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.21252955 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.11043806 |
| 5 | Xanthomatosis (HP:0000991) | 5.92388734 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.63681069 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.54766621 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.12463444 |
| 9 | Hyperglycinemia (HP:0002154) | 4.92424879 |
| 10 | Hyperammonemia (HP:0001987) | 4.91632141 |
| 11 | * Hyperglycinuria (HP:0003108) | 4.75507462 |
| 12 | Ketosis (HP:0001946) | 4.71840638 |
| 13 | * Abnormality of glycine metabolism (HP:0010895) | 4.55607186 |
| 14 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 4.55607186 |
| 15 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.43262559 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.41025009 |
| 17 | Complement deficiency (HP:0004431) | 4.40940942 |
| 18 | * Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.36821347 |
| 19 | Hypolipoproteinemia (HP:0010981) | 4.30119642 |
| 20 | Joint hemorrhage (HP:0005261) | 4.23907736 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.11689861 |
| 22 | Epidermoid cyst (HP:0200040) | 3.94336275 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.90067687 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.89420322 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.89007705 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.87577103 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79027150 |
| 28 | Fat malabsorption (HP:0002630) | 3.74438998 |
| 29 | Ketoacidosis (HP:0001993) | 3.68935708 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.65891108 |
| 31 | Bronchomalacia (HP:0002780) | 3.56143947 |
| 32 | Gout (HP:0001997) | 3.53915919 |
| 33 | Delayed CNS myelination (HP:0002188) | 3.51363007 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.45418277 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42435389 |
| 36 | Myokymia (HP:0002411) | 3.35305694 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.35141939 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33180760 |
| 39 | Abnormality of purine metabolism (HP:0004352) | 3.28613841 |
| 40 | Hypercholesterolemia (HP:0003124) | 3.28469288 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.21444308 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.21444308 |
| 43 | Hyperbilirubinemia (HP:0002904) | 3.19294788 |
| 44 | Conjugated hyperbilirubinemia (HP:0002908) | 3.17613306 |
| 45 | Abnormality of complement system (HP:0005339) | 3.13586680 |
| 46 | Metabolic acidosis (HP:0001942) | 3.12364518 |
| 47 | * Hydroxyprolinuria (HP:0003080) | 3.11456160 |
| 48 | * Abnormality of proline metabolism (HP:0010907) | 3.11456160 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.96499321 |
| 50 | Lethargy (HP:0001254) | 2.96278141 |
| 51 | Proximal tubulopathy (HP:0000114) | 2.87078267 |
| 52 | Steatorrhea (HP:0002570) | 2.86482035 |
| 53 | Vascular calcification (HP:0004934) | 2.83703931 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 2.73130085 |
| 55 | Decreased circulating renin level (HP:0003351) | 2.72965708 |
| 56 | Alkalosis (HP:0001948) | 2.69080252 |
| 57 | Ankle clonus (HP:0011448) | 2.58827129 |
| 58 | Myocardial infarction (HP:0001658) | 2.58481775 |
| 59 | Cerebral edema (HP:0002181) | 2.55895760 |
| 60 | Amelogenesis imperfecta (HP:0000705) | 2.52008107 |
| 61 | Hyperventilation (HP:0002883) | 2.51823044 |
| 62 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.51685415 |
| 63 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.51685415 |
| 64 | Increased purine levels (HP:0004368) | 2.49867830 |
| 65 | Hyperuricemia (HP:0002149) | 2.49867830 |
| 66 | Spastic diplegia (HP:0001264) | 2.49419736 |
| 67 | Malnutrition (HP:0004395) | 2.47705460 |
| 68 | Neonatal onset (HP:0003623) | 2.46785412 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.46283241 |
| 70 | Vomiting (HP:0002013) | 2.44789672 |
| 71 | Widely patent fontanelles and sutures (HP:0004492) | 2.43594887 |
| 72 | Irritability (HP:0000737) | 2.43573746 |
| 73 | Late onset (HP:0003584) | 2.40690352 |
| 74 | Focal seizures (HP:0007359) | 2.40107859 |
| 75 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.38450954 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.38061719 |
| 77 | Spontaneous abortion (HP:0005268) | 2.37007973 |
| 78 | Abnormality of renin-angiotensin system (HP:0000847) | 2.36941423 |
| 79 | Enlarged kidneys (HP:0000105) | 2.36503139 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.34806831 |
| 81 | Skin nodule (HP:0200036) | 2.34019822 |
| 82 | Potter facies (HP:0002009) | 2.31328457 |
| 83 | Facial shape deformation (HP:0011334) | 2.31328457 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.30674607 |
| 85 | Abnormality of vitamin B metabolism (HP:0004340) | 2.30669440 |
| 86 | Pancreatitis (HP:0001733) | 2.30340898 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 2.25386649 |
| 88 | Glycosuria (HP:0003076) | 2.25386649 |
| 89 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.25187693 |
| 90 | Absent/shortened dynein arms (HP:0200106) | 2.25187693 |
| 91 | Focal motor seizures (HP:0011153) | 2.21897560 |
| 92 | Hypochromic microcytic anemia (HP:0004840) | 2.17062285 |
| 93 | Hypoplastic ischia (HP:0003175) | 2.15291699 |
| 94 | Ependymoma (HP:0002888) | 2.14769922 |
| 95 | Aplasia involving bones of the extremities (HP:0009825) | 2.14711738 |
| 96 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.14711738 |
| 97 | Aplasia of the phalanges of the hand (HP:0009802) | 2.14711738 |
| 98 | Rickets (HP:0002748) | 2.11159071 |
| 99 | Abnormal ciliary motility (HP:0012262) | 2.10111417 |
| 100 | Amyloidosis (HP:0011034) | 2.09751121 |
| 101 | Split foot (HP:0001839) | 2.07348105 |
| 102 | Abnormality of the ischium (HP:0003174) | 2.06289345 |
| 103 | Epileptic encephalopathy (HP:0200134) | 2.05495082 |
| 104 | Esophageal varix (HP:0002040) | 2.05261051 |
| 105 | Mitral stenosis (HP:0001718) | 2.04819909 |
| 106 | Brushfield spots (HP:0001088) | 2.03032457 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 2.02683224 |
| 108 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.02476283 |
| 109 | Acanthocytosis (HP:0001927) | 2.00799161 |
| 110 | Confusion (HP:0001289) | 2.00798436 |
| 111 | Cholelithiasis (HP:0001081) | 2.00481301 |
| 112 | Opisthotonus (HP:0002179) | 1.99737418 |
| 113 | Megaloblastic anemia (HP:0001889) | 1.99388779 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98779228 |
| 115 | Heart block (HP:0012722) | 1.97993896 |
| 116 | Febrile seizures (HP:0002373) | 1.97525144 |
| 117 | Back pain (HP:0003418) | 1.96889446 |
| 118 | Progressive cerebellar ataxia (HP:0002073) | 1.96386055 |
| 119 | Abnormal urine phosphate concentration (HP:0012599) | 1.95464629 |
| 120 | Renal cortical cysts (HP:0000803) | 1.95195256 |
| 121 | Glomerulonephritis (HP:0000099) | 1.94437347 |
| 122 | Action tremor (HP:0002345) | 1.92881794 |
| 123 | Abnormality of the dental pulp (HP:0006479) | 1.92403952 |
| 124 | Hyperactive renin-angiotensin system (HP:0000841) | 1.91433158 |
| 125 | Elevated hepatic transaminases (HP:0002910) | 1.90162934 |
| 126 | Thrombophlebitis (HP:0004418) | 1.89911299 |
| 127 | Methylmalonic aciduria (HP:0012120) | 1.89738052 |
| 128 | Abnormality of vitamin metabolism (HP:0100508) | 1.86747283 |
| 129 | Stomach cancer (HP:0012126) | 1.86733614 |
| 130 | Nephronophthisis (HP:0000090) | 1.86448537 |
| 131 | Menorrhagia (HP:0000132) | 1.85679942 |
| 132 | Chronic bronchitis (HP:0004469) | 1.85481271 |
| 133 | Nausea (HP:0002018) | 1.84910506 |
| 134 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.84701790 |
| 135 | Abnormal cartilage morphology (HP:0002763) | 1.84503884 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 1.83974847 |
| 137 | Cholecystitis (HP:0001082) | 1.83974847 |
| 138 | Abnormality of the dental root (HP:0006486) | 1.83556417 |
| 139 | Taurodontia (HP:0000679) | 1.83556417 |
| 140 | Abnormality of permanent molar morphology (HP:0011071) | 1.83556417 |
| 141 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.83530339 |
| 142 | Bell-shaped thorax (HP:0001591) | 1.82980945 |
| 143 | Decreased central vision (HP:0007663) | 1.80727892 |
| 144 | Gingival bleeding (HP:0000225) | 1.79734528 |
| 145 | Hypophosphatemic rickets (HP:0004912) | 1.78999771 |
| 146 | Focal segmental glomerulosclerosis (HP:0000097) | 1.78720579 |
| 147 | Protuberant abdomen (HP:0001538) | 1.78008477 |
| 148 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.77953857 |
| 149 | Nephrolithiasis (HP:0000787) | 1.77479917 |
| 150 | Cystic liver disease (HP:0006706) | 1.75891075 |
| 151 | Abnormality of renal excretion (HP:0011036) | 1.75375687 |
| 152 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75333584 |
| 153 | Tubular atrophy (HP:0000092) | 1.75139498 |
| 154 | Abnormal urine output (HP:0012590) | 1.74934076 |
| 155 | Pendular nystagmus (HP:0012043) | 1.74882676 |
| 156 | Genetic anticipation (HP:0003743) | 1.74571660 |
| 157 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.73832191 |
| 158 | Turricephaly (HP:0000262) | 1.72930321 |
| 159 | Lymphangioma (HP:0100764) | 1.72847706 |
| 160 | Rhinitis (HP:0012384) | 1.71028797 |
| 161 | Mixed hearing impairment (HP:0000410) | 1.70107515 |
| 162 | Partial duplication of thumb phalanx (HP:0009944) | 1.70038619 |
| 163 | Abnormal eating behavior (HP:0100738) | 1.69414210 |
| 164 | Septo-optic dysplasia (HP:0100842) | 1.69112466 |
| 165 | Abnormal atrioventricular conduction (HP:0005150) | 1.68496769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.00139057 |
| 2 | SIK1 | 4.56269907 |
| 3 | ERN1 | 4.12494807 |
| 4 | EPHA2 | 3.77587891 |
| 5 | FGFR4 | 3.51241101 |
| 6 | NTRK3 | 2.99779072 |
| 7 | INSRR | 2.59204232 |
| 8 | TAOK3 | 2.55054361 |
| 9 | STK38L | 2.36984204 |
| 10 | LATS2 | 2.28755096 |
| 11 | MARK1 | 2.27732394 |
| 12 | CASK | 2.27335761 |
| 13 | ACVR1B | 2.27080745 |
| 14 | NME1 | 2.23445838 |
| 15 | TRIB3 | 2.16716409 |
| 16 | ERBB4 | 2.12254950 |
| 17 | WNK3 | 2.11095348 |
| 18 | MST1R | 1.95371368 |
| 19 | WNK4 | 1.94002102 |
| 20 | PKN2 | 1.92229932 |
| 21 | MAP3K7 | 1.87670665 |
| 22 | MAPK11 | 1.81099183 |
| 23 | NTRK2 | 1.77332364 |
| 24 | FLT3 | 1.63041614 |
| 25 | PINK1 | 1.62442566 |
| 26 | MAPK13 | 1.60171740 |
| 27 | OXSR1 | 1.57673097 |
| 28 | PRKG2 | 1.51165892 |
| 29 | MAP2K4 | 1.47131046 |
| 30 | TNIK | 1.44368677 |
| 31 | EPHA4 | 1.44313855 |
| 32 | PIK3CG | 1.42584653 |
| 33 | TYRO3 | 1.35691303 |
| 34 | MATK | 1.35236162 |
| 35 | GRK6 | 1.29219957 |
| 36 | PRKCI | 1.24418381 |
| 37 | TYK2 | 1.24116248 |
| 38 | ABL2 | 1.23416024 |
| 39 | BMPR1B | 1.22321371 |
| 40 | LMTK2 | 1.20206197 |
| 41 | LATS1 | 1.19899847 |
| 42 | PTK6 | 1.18724810 |
| 43 | KDR | 1.18605201 |
| 44 | FRK | 1.17635892 |
| 45 | PRKAA2 | 1.15186978 |
| 46 | IRAK3 | 1.14396030 |
| 47 | MAPK12 | 1.09180025 |
| 48 | MAP2K3 | 1.07932955 |
| 49 | EEF2K | 1.03861763 |
| 50 | PAK6 | 1.00478626 |
| 51 | PDK3 | 0.99782010 |
| 52 | PDK4 | 0.99782010 |
| 53 | MAPK4 | 0.99101477 |
| 54 | TIE1 | 0.98784613 |
| 55 | JAK2 | 0.95507652 |
| 56 | ADRBK2 | 0.95245182 |
| 57 | SIK2 | 0.94379051 |
| 58 | STK11 | 0.93069434 |
| 59 | PRKCG | 0.92713699 |
| 60 | PAK3 | 0.91993226 |
| 61 | UHMK1 | 0.91266140 |
| 62 | NUAK1 | 0.90867945 |
| 63 | CAMK2B | 0.85852805 |
| 64 | NEK9 | 0.85435458 |
| 65 | SGK3 | 0.84334268 |
| 66 | CAMK2A | 0.84170398 |
| 67 | ERBB2 | 0.82282154 |
| 68 | MAP2K6 | 0.81085536 |
| 69 | FER | 0.81078360 |
| 70 | DAPK1 | 0.80930872 |
| 71 | FGFR2 | 0.80742315 |
| 72 | MINK1 | 0.80335892 |
| 73 | CDK5 | 0.79983845 |
| 74 | TBK1 | 0.79315908 |
| 75 | SGK2 | 0.79255424 |
| 76 | MAPKAPK3 | 0.78574778 |
| 77 | NEK6 | 0.78482974 |
| 78 | RPS6KA2 | 0.77556245 |
| 79 | MAP3K3 | 0.77007727 |
| 80 | STK16 | 0.74780798 |
| 81 | MAP3K14 | 0.74661052 |
| 82 | CAMKK1 | 0.74414188 |
| 83 | SGK494 | 0.70706826 |
| 84 | SGK223 | 0.70706826 |
| 85 | TGFBR2 | 0.70554413 |
| 86 | PRKAA1 | 0.70235935 |
| 87 | PRKD3 | 0.69775207 |
| 88 | DYRK2 | 0.69508759 |
| 89 | BMX | 0.69102799 |
| 90 | PIK3CA | 0.68264298 |
| 91 | PRKCZ | 0.67944164 |
| 92 | PRKACG | 0.67509017 |
| 93 | DAPK2 | 0.67326174 |
| 94 | TAOK2 | 0.67259354 |
| 95 | STK38 | 0.67203680 |
| 96 | CAMK1 | 0.66280640 |
| 97 | MYLK | 0.66163533 |
| 98 | MUSK | 0.66111219 |
| 99 | OBSCN | 0.65283497 |
| 100 | PDPK1 | 0.64946525 |
| 101 | MARK2 | 0.63891774 |
| 102 | CSNK1A1 | 0.63402063 |
| 103 | CAMK1D | 0.62695895 |
| 104 | PRKACA | 0.62281473 |
| 105 | NTRK1 | 0.61768308 |
| 106 | SGK1 | 0.61515357 |
| 107 | TLK1 | 0.60921219 |
| 108 | GRK1 | 0.60793643 |
| 109 | JAK1 | 0.58999720 |
| 110 | PTK2 | 0.54721084 |
| 111 | PKN1 | 0.54169812 |
| 112 | MAPKAPK5 | 0.54142335 |
| 113 | BCR | 0.53115945 |
| 114 | FGFR1 | 0.52106158 |
| 115 | MAPK7 | 0.52096018 |
| 116 | PDK2 | 0.50878577 |
| 117 | MAP2K2 | 0.50713527 |
| 118 | NEK1 | 0.50674207 |
| 119 | CDK4 | 0.49855078 |
| 120 | MAPK15 | 0.48906918 |
| 121 | CAMK2D | 0.48539544 |
| 122 | RIPK1 | 0.46779205 |
| 123 | CAMK2G | 0.45727200 |
| 124 | FGFR3 | 0.45525735 |
| 125 | MAPK8 | 0.45506299 |
| 126 | GSK3A | 0.45321484 |
| 127 | MAP3K11 | 0.44547041 |
| 128 | PRKCQ | 0.44295986 |
| 129 | AKT3 | 0.44285142 |
| 130 | MAP3K4 | 0.44240619 |
| 131 | RPS6KA6 | 0.44121590 |
| 132 | PDK1 | 0.44003119 |
| 133 | PHKG1 | 0.43984197 |
| 134 | PHKG2 | 0.43984197 |
| 135 | DYRK1A | 0.43592383 |
| 136 | TEC | 0.43202664 |
| 137 | CSNK1E | 0.41044313 |
| 138 | MAPK10 | 0.40869878 |
| 139 | MST4 | 0.40868690 |
| 140 | CDK15 | 0.40308358 |
| 141 | RPS6KA3 | 0.39635008 |
| 142 | LRRK2 | 0.39570572 |
| 143 | MET | 0.39072580 |
| 144 | GSK3B | 0.38994798 |
| 145 | PRKCE | 0.38762695 |
| 146 | EPHB1 | 0.37449389 |
| 147 | IGF1R | 0.36920804 |
| 148 | IKBKE | 0.36499096 |
| 149 | CSK | 0.36353035 |
| 150 | MAP3K13 | 0.36338095 |
| 151 | BTK | 0.34279303 |
| 152 | CSF1R | 0.34202074 |
| 153 | CDK6 | 0.34130828 |
| 154 | PRKCA | 0.28845323 |
| 155 | AKT2 | 0.28496121 |
| 156 | MAP3K6 | 0.28490252 |
| 157 | KIT | 0.26293235 |
| 158 | CAMK4 | 0.25500263 |
| 159 | STK39 | 0.24394074 |
| 160 | DYRK1B | 0.24202638 |
| 161 | MAP3K10 | 0.24032634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.04327196 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.60537094 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40309732 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06589792 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89148070 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.72162612 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71765652 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64019281 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.63591819 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60224501 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.51682821 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41705719 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29594094 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28516367 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.28247962 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.22556095 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02016628 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99888870 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88944637 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88248044 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81667999 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.80386202 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79835979 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77126583 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76957243 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71002506 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68225263 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67770948 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64041419 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62158398 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62040456 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59837802 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58894684 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.51137992 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47483750 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46775630 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43127626 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.39255971 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38398302 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.37584688 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36328398 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36309585 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36210307 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34398350 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33761045 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33041278 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.31730343 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27899189 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27192910 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21193860 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.15146216 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.11161334 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08405847 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08299493 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06450080 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02327726 |
| 57 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99630645 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97860830 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96935994 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95300379 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95126527 |
| 62 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.92861640 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90647815 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89663504 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.87141610 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87039995 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83092553 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82589910 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81645387 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.79586393 |
| 71 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78831630 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77880651 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77830338 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77798432 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77502496 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72169353 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72166174 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.72051638 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71745610 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.71637731 |
| 81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71386446 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70519470 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.69196717 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.69155125 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64785013 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60514530 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60476925 |
| 88 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59080359 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55758612 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55074868 |
| 91 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54184170 |
| 92 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53985184 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.53286741 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.51379427 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50761622 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50200269 |
| 97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48057672 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.46326885 |
| 99 | Renin secretion_Homo sapiens_hsa04924 | 0.42487636 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42366079 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41169662 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39056777 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38859162 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26959578 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25352191 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24864662 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.21308946 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15744028 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15120540 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.10864323 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06909533 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03056189 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01862695 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01724522 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00073645 |
| 116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2264011 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2220177 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2097875 |
| 119 | Lysosome_Homo sapiens_hsa04142 | -0.1937622 |
| 120 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1846095 |
| 121 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1788669 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | -0.1786841 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1739525 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1331209 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1329914 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1320243 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | -0.1093826 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1023001 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1020674 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0817169 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0621687 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0173968 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0081053 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0022546 |

